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Abstract
Background: Children and adolescents with juvenile idiopathic arthritis (JIA) may suffer pain from temporomandibular
disorder (TMD). Still, routines for the assessment of temporomandibular joint (TMJ) pain in health and dental care are
lacking. The aims of this study were to examine the prevalence of TMD in children and adolescents with JIA compared
to their healthy peers and to investigate potential associations between JIA and TMD.
Methods: This comparative cross-sectional study is part of a longitudinal multicentre study performed during 2015–
2020, including 228 children and adolescents aged 4–16 years with a diagnosis of JIA according to the ILAR criteria.
This particular substudy draws on a subset of data from the first study visit, including assessments of TMD as part of a
broader oral health examination. Children and adolescents with JIA were matched with healthy controls according to
gender, age, and centre site. Five calibrated examiners performed the clinical oral examinations according to a
standardised protocol, including shortened versions of the diagnostic criteria for TMD (DC/TMD) and the TMJaw
Recommendations for Clinical TMJ Assessment in Patients Diagnosed with JIA. Symptoms were recorded and followed
by a clinical examination assessing the masticatory muscles and TMJs.
Results: In our cohort of 221 participants with JIA and 221 healthy controls, 88 (39.8%) participants with JIA and 25
(11.3%) healthy controls presented with TMD based on symptoms and clinical signs. Painful TMD during the last 30
days was reported in 59 (26.7%) participants with JIA vs. 10 (5.0%) of the healthy controls (p < 0.001). Vertical
unassisted jaw movement was lower in participants with JIA than in controls, with means of 46.2 mm vs. 49.0 mm,
respectively (p < 0.001). Among participants with JIA, a higher proportion of those using synthetic disease-modifying
antirheumatic-drugs and biologic disease-modifying antirheumatic-drugs presented with painful masticatory muscles
and TMJs at palpation.
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Conclusion: Symptoms and clinical signs of TMD were seen in approximately half of the JIA patients compared to
about one fourth of their healthy peers. Painful palpation to masticatory muscles and decreased vertical unassisted jaw
movement were more frequent in participants with JIA than among healthy controls and should be part of both
medical and dental routine examinations in patients with JIA.
Keywords: Juvenile idiopathic arthritis, Temporomandibular joint arthritis, Temporomandibular disorder,
Temporomandibular joint disease, Children and adolescents
Background
Juvenile idiopathic arthritis (JIA) is currently the most
common chronic rheumatic disease in children and ado-
lescents [1, 2]. The International League of Associations
of Rheumatology (ILAR) defines JIA as arthritis of un-
known aetiology, starting before the age of 16 years with
a duration of at least 6 weeks [3]. It encompasses seven
categories, including systemic arthritis, oligoarthritis
(persistent or extended), rheumatoid factor negative
polyarthritis, rheumatoid factor positive polyarthritis,
psoriatic arthritis, and enthesitis-related arthritis with
different, though overlapping, characteristics. Cases that
fit none or more than one of these categories are defined
as undifferentiated arthritis. The burden of JIA is charac-
terised by short and long-term functional disability and
pain. Common features at presentation are morning
stiffness, swelling of one or more joints, functional dis-
turbances, and sometimes pain. The reported prevalence
is around 1–2 cases per 1000 children, with girls more
frequently affected than boys [1, 2].
Temporomandibular disorder (TMD), known as an
umbrella or collective term for muscle pain and jaw dys-
function, covers a heterogeneous group of conditions
[4]. TMD is associated with various clinical signs and
symptoms involving the masticatory muscles, teeth,
tongue, temporomandibular joint (TMJ), and/or their
supportive tissues [5–7]. Changes in motor behaviour
caused by musculoskeletal pain and pain-related move-
ment disorders reflect sustained pain perception. In two
recent studies from Western Norway [8, 9], the preva-
lence of painful TMD among otherwise healthy adoles-
cents was reported to be around 7% based on self-
reported pain screening questionnaires adopted by Nils-
son and colleagues [10]. In the study by Graue and col-
leagues [9], the prevalence of TMD was 11.9% when
using the Diagnostic Criteria for Temporomandibular
Disorders (DC/TMD). In all three studies, females were
more frequently affected than males.
In children and adolescents with JIA, the reported fig-
ures are substantially higher. Previous studies of chil-
dren and adolescents with JIA reported a broad
spectrum of TMD prevalence ranging between 39 and
87% [11–13], depending on the study designs and the
sample size. Therefore, it is a need to reinforce the
evidence with a relatively high number of samples and
give insights to the effects of medication in JIA partici-
pants when they are examined by palpation of mastica-
tory muscles and TMJ.
Previous studies revealed that children and adolescents,
irrespective of their JIA category, are prone to develop
TMJ arthritis [11, 14]. Also, younger children with JIA
might suffer pain from TMJs caused by inflammation
and/or destructive changes, by muscular tensions from
the surrounding muscles as a component of TMD, or by a
combination of the two [12]. Symptoms indicating TMJ
arthritis include decreased mouth opening and/or ear ache
and pain during eating, chewing, or yawning [15–17]. At
present, there are no precise clinical or imaging markers
for active TMJ arthritis [18, 19]. As for TMJ involvement,
several studies have shown that even significant deform-
ities may be undiagnosed due to a lack of symptoms or
clinical findings [16, 20–22]. In younger children, the clin-
ical assessment of painful TMD symptoms might be
biased by indirect input from their parents.
The aims of the present study were to examine the
prevalence of TMD in children and adolescents with JIA
compared to their healthy peers and to investigate po-
tential associations between JIA and TMD.
Methods
Study design and participants
This cross-sectional study was part of a longitudinal
multicentre study, the NorJIA study, performed during
2015–2020 and including 228 children and adolescents.
Inclusion criteria were a diagnosis of JIA according to
the ILAR [3] and age 4–16 years. In the exclusion cri-
teria, absent of written informed consent or major med-
ical comorbidities such as congenital facial anomalies,
skeletal dysplasia or malignancies were excluded.
This particular substudy (2015–2018), using a matched
comparative cross-sectional design, drew on a subset of
data from the first study visit, including assessments of
TMD as part of a broader oral health examination. Chil-
dren and adolescents were matched (1:1) with healthy
controls according to gender, age, and centre site. The
healthy controls were recruited from seven different
Public Dental Service clinics representing both rural and
urban areas in the western, middle, and northern parts
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of Norway. The sample size estimate was based on a
Swedish study reporting a TMD prevalence of 26% in
children with JIA [23], and a sample size of 296 was re-
quired for a precision of 5% with a 95% confidence
interval.
Data collection
At the study visits, children and adolescents with JIA
were examined by experienced paediatric rheumatolo-
gists at Haukeland University Hospital in Bergen, Uni-
versity Hospital of North Norway in Tromsø, and St.
Olavs University Hospital in Trondheim. Registered data
included background characteristics in terms of age at
disease onset, disease category, disease status on the day
of the examination, a thorough joint examination, blood
tests, and validated measures for patient-reported dis-
ability, general body pain, and health assessments. Fur-
thermore, the applied dose was according to the
international recommendations, while duration varied
significantly, with or without combination with other
medication. However, detailed drug history concerning
duration and doses was not available in the study data-
base. Both children and adolescents with JIA and con-
trols underwent a thorough clinical oral examination
performed by experienced dentists, including a TMD
assessment.
TMD screening and assessment
The assessment procedures were standardised and were
based on two shortened versions of the diagnostic tools
“Axis I Clinical Examination for DC/TMD” [20] and the
self-assessment questionnaire “TMJaw Recommenda-
tions for Clinical TMJ Assessment in Patients Diagnosed
with JIA” [21]. The latter was used to enhance the oper-
ational specification of DC/TMD due to the fact that the
DC/TMD tool alone is reported to show weak validity
for TMJ assessment, e.g. disc displacement diagnosis
(low sensitivity) and degenerative joint disease diagnosis
(low sensitivity and specificity) [20].
Prior to and during the study period, calibration ses-
sions for the five participating oral examiners were per-
formed, including four calibration exercises according to
procedures previously described by our research team
[22]. Further details on the calibration results are pre-
sented in Supplementary Tables S1 and S2.
Variables and outcomes
The demographic variables were age, gender, JIA cat-
egories, and medication status. The subjective symptom
outcomes were TMD pain in the last 30 days (n, %) re-
ported by the participants or the parents. The examining
dentists also registered how many of the individuals
expressed pain during jaw movement in the clinical
examination (n, %). The clinical outcomes included
vertical and lateral unassisted jaw movements (mm),
pain upon palpation of the masticatory muscles and the
TMJ (n), and if the TMJ disc was clicking in a painful
manner (n).
Statistical methods
Two-way mixed intraclass correlation coefficient (ICC)
and percent agreement were used for calibration mea-
surements. Differences between groups were tested
using Chi-square statistics or a two-sample t-test as ap-
propriate. All statistical tests were performed using SPSS
version 25 (IBM, Chicago, IL). The level of statistical sig-
nificance was set at 5% (p ≤ 0.05).
Ethical considerations
The study was approved by the regional ethics commit-
tee (2012/542/REK vest). Written informed consents
were obtained from all parents and/or participants as ap-
propriate. The study was registered at ClinicalTrials.gov
(No: NCT03904459).
Results
A total of 360 children and adolescents with JIA were
eligible for the main study, of whom 228 accepted the
invitation to participate, yielding a response rate of
63.3%. The acceptance rate for healthy controls was 224/
294 (76.2%). The mean age for participants with JIA and
healthy controls was 12.0 years (SD 3.17 and 3.21, re-
spectively) (p = 0.98), and the mean age of the 228 par-
ticipants with JIA was higher than for the 132 eligible
patients that did not participate at 12.0 years vs. 10.5
years (SD 3.16 and 3.5, respectively) (p < 0.001). The
proportion of girls with JIA was also higher than among
the 132 patients not participating (59.2% vs. 58.3%, p =
0.027). Among the 228 participating children with JIA,
224 underwent an oral examination and 221 underwent
the TMD assessment and were thus included in the
present substudy (Fig. 1).
Of the 221 children with JIA, 132 were girls (59.7%), the
median age at disease onset was 6.1 years (IQR 8.1, 2.3–
10.4), the median age at the study visit by paediatric rheu-
matologists at the hospital was 12.7 years (IQR (5.3, 9.4–
14.7), and the median disease duration was 4.6 years (IQR
5.7, 2.6–8.3) (Table 1). Oligoarticular JIA was the most
common category and was seen in 98 of 221 patients
(44.3%) with 77 having persistent oligoarticular disease and
21 having extended disease. In total, 146 of the 221 patients
(66.1%) had on-going medication with synthetic disease-
modifying antirheumatic-drugs (sDMARDs) and/or bio-
logic disease-modifying antirheumatic-drugs (bDMARDs).
Clinical oral examination
Taking into consideration that self-reported pain is a
combination of parent-reported and participant-reported
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pain outcome, self-reported pain in the jaws during the
last 30 days was reported in 59 (26.7%, 44 girls) partici-
pants with JIA vs. 10 (5%, 8 girls) in healthy controls
(p < 0.001). Pain during jaw movements at the clinical
examination was reported in 112 (51%, 67 girls)
participants with JIA vs. 59 (26.8%, 34 girls) in healthy
controls (p < 0.001) (Fig. 2), ranging from 28.6 to 50% in
the different JIA categories (Table 1). No statistically sig-
nificant differences in the presence of TMD according to
JIA categories were found (p = 0.848) (results not shown).
Fig. 1 Flow chart of patients and healthy individuals included in the study
Table 1 Clinical characteristics of participants with Juvenile idiopathic arthritis (JIA) in relation to temporomandibular disorder (TMD)
Total cohort TMD No TMD
n = 221 n = 88 n = 133
Value Value Value
Girls, n (%) 132 (59.7) 61 (69.3) 71 (53.4)
Age at onset, median (IQR) 6.1 (8.1, 2.3–10.4) 6.8 (8.4, 0.7–14.2) 5.2 (7.2, 0.9–14.7)
Age at visit by paediatric rheumatologists at the hospital, median (IQR) 12.7 (5.3, 9.4–14.7) 13.1 (3.3, 5.2–16.1) 11.7 (6.5, 4.8–16.5)
Disease duration, median (IQR) 4.6 (5.7, 2.6–8.3) 4.6 (6.0, 0.2–14.2) 4.6 (5.5, 0.2–14.7)
JIA categories, n (%)
Oligoarthritis persistent 77 (34.8) 27 (30.7) 50 (37.6)
Oligoarthritis extended 21 (9.5) 11 (12.5) 10 (7.5)
Systemic arthritis 7 (3.2) 2 (2.3) 5 (3.8)
RF negative polyarthritis 49 (22.2) 17 (19.3) 32 (24.1)
RF positive polyarthritis 4 (1.8) 2 (2.3) 2 (1.5)
Psoriatic arthritis 9 (4.1) 6 (6.8) 3 (2.3)
Enthesitis-related arthritis 23 (10.4) 9 (10.2) 14 (10.5)
Undifferentiated JIA 31 (14.0) 14 (15.9) 17 (12.8)
Ongoing medication, n (%)
No DMARDs 75 (33.9) 26 (11.8) 49 (22.2)
sDMARDs* 60 (27.1) 23 (10.4) 37 (16.7)
bDMARDs** 86 (38.9) 39 (17.6) 47 (21.3)
JIA Juvenile idiopathic arthritis, TMD Temporomandibular disorder
*sDMARDs = Synthetic disease-modifying antirheumatic- drugs; methotrexate, mykofenolatmofetil, **bDMARDs = Biologic disease-modifying antirheumatic-drugs;
etanercept, infliximab, adalimumab, tocilizumab, abatacept, certolizumab, golimumab
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The clinical examination revealed that the mean vertical
unassisted jaw movement was lower for participants with
JIA than for controls, 46.2mm vs. 49.0mm, respectively
(p < 0.001) (Table 2). A total of 88 (39.8%, 61 girls) partic-
ipants with JIA and 25 (11.3%, 17 girls) healthy controls
had both symptoms and clinical signs of TMD (Fig. 2).
When assessing the jaw muscles and TMJ, 111 (50.2%, 75
girls) participants with JIA had both painful masticatory
muscles and TMJs on palpation vs. 62 (28.2%, 39 girls) of
the healthy controls (p < 0.001) (Table 3). A higher pro-
portion of participants on current sDMARDs and/or
bDMARDs treatment presented with painful masticatory
muscles and TMJ at palpation compared to participants
with no biologic treatment (Table 4).
Among participants with JIA, there were no significant
differences in vertical unassisted jaw movement accord-
ing to medication, with a mean of 46.4 mm (SD 7.1) in
the JIA group and 45.8 mm (SD 7.1) among those not
using DMARDs (p = 0.986) (results not shown). How-
ever, in both groups, more than half of the participants
had a vertical unassisted jaw movement of more than 40
mm. The proportion without this medication treatment
was slightly higher (82.7%) compared to those on
current sDMARDs and/or bDMARDs (77.4%).
Fig. 2 Prevalence of TMD in children and adolescents with JIA vs. healthy peers, ≥ 10 years and < 10 years of age, 1) symptoms: pain the last 30
days and pain with jaw movements; 2) clinical signs: pain upon palpation of the masticatory muscles and TMJ, and 3) a combination of
symptoms (1) and clinical signs (2)
Table 2 Jaw movement in 221 participants with JIA compared to controls
Jaw movement n JIA n Healthy controls p-value*
mm mm
mean (SD) mean (SD)
Vertical unassisted 221 46.2 (7.1) 221 49.0 (6.7) < 0.001
Lateral to the right side 215 9.7 (2.2) 220 9.8 (2.1) 0.408
Lateral to the left side 211 9.7 (2.4) 219 10.1 (2.0) 0.077
JIA Juvenile idiopathic arthritis, SD Standard deviation. *Student’s t-test
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Discussion
We have shown using a comparative cross-sectional
multicentre design that around one third of the partici-
pants with JIA in this cohort had TMD. Half of children
and adolescents with JIA reported pain during jaw
movements and pain on palpation of the masticatory
muscles and TMJs as compared to one fourth of their
healthy peers, palpatory pain was associated with
sDMARDs and bDMARDs treatment, and children and
adolescents with JIA had a significantly lower mean ver-
tical unassisted jaw movement. Moreover, TMJ-related
clinical signs and vertical unassisted jaw movement ≤40
mm had the highest association in the JIA group.
The reported prevalence of TMD in children with JIA
varies between 38 and 83% according to the definitions
and methods of ascertainment used, to the cohort exam-
ined, and to differences in populations [15, 24–27]. Fer-
raz and colleagues, in their study of 15 children with JIA
ranging in age from 6 to 28 years (mean age 16.3 years),
reported a high prevalence of 83%. Still, they did not de-
scribe the method of ascertainment, i.e., whether the fig-
ures were based on self-reporting or on clinical
examination [28]. A previous study from Rongo and col-
leagues based on 50 participants with JIA aged 9–16
years found a prevalence of TMJ damage from 100 joints
to be 74% as assessed by MRI [25]. Others have reported
a prevalence of 55% based on a questionnaire [29] and
of 72% based on clinical signs [24]. However, none of
those studies were based on the research diagnostic cri-
teria RDC/TMD, and the children were older than those
in our study. In contrast, a longitudinal study by Zwir
et al., including 75 children (mean age 12.4 years),
revealed a prevalence of 38% based on symptoms and
47% based on clinical examination [30]. Their results are
in line with ours.
In our study, the prevalence of TMD, either based on
symptoms or clinical signs, in the healthy peers, were
quite high at 28 and 29%, respectively. This was higher
than in earlier studies among adolescents reported by
Graue and colleagues (7 and 12%, respectively) and
Østensjø and colleagues (7%) [8, 9]. Studies from Finland
and Brazil confirm our results with a high prevalence of
TMD in the normal population. Vierola et al. [26] re-
ported a TMD prevalence of 35% (mean age 7.9 years)
and de Paiva Bertoli reported a TMD prevalence of 34%
(mean age 11.0 years) [27]. The difference in TMD
prevalence in the normal population of children and ad-
olescents is probably due to the use of different diagnos-
tic tools, different numbers of participants, different ages
of the studied populations, different countries, and dif-
ferent study designs. In studies from Norway, Graue and
colleagues [9] used two screening questions for pain re-
lated to TMD [10] and DC/TMD [20] for symptoms and
clinical signs in a population of 210 children and adoles-
cents aged 12–19 years. Østensjø et al. [8] used the same
two screening questions of TMD symptoms [10] for
screening a population of 560 adolescents aged 13–19
years. Then a modified RDC/TMD examination [31] was
used for those who answered yes to 1) having pain in
the temples, face, TMJ, or jaws once a week or more
and 2) having pain once a week or more when opening
the mouth wide or chewing. The Finnish group [26]
used the RDC/TMD [31] for clinical signs in 483 chil-
dren aged 6–8 years, and the Brazilian group [27] used
Table 3 Pain on palpation and painful clicking in participants with JIA and controls
Clinical signs n JIA, n (%) n Healthy controls n (%) p-value*
Painful palpation in masticatory muscles & TMJ 220 111 (50.5) 220 62 (28.2) < 0.001
Painful palpation in masticatory muscle 217 87 (40.1) 218 44 (20.2) < 0.001
Painful palpation at the TMJ lateral pole 220 64 (29.1) 219 29 (13.2) < 0.001
Painful palpation around TMJ lateral pole 220 75 (34.1) 219 33 (15.1) < 0.001
Painful clicking 221 13 (5.9) 221 2 (0.9) 0.0041
JIA Juvenile idiopathic arthritis, TMJ Temporomandibular joints. *Chi-square test
Table 4 Clinical signs and pain at palpation according to DMARDs in 221 participants with JIA
Current sDMARDs and/or bDMARDs No current sDMARDs and/or bDMARDs p-value*
n n (%) n n (%)
Vertical unassisted jaw movement (> 40 mm) 146 113 (77.4) 75 62 (82.7) 0.361
Painful palpation to masticatory muscles & TMJ 145 80 (72.1) 75 31 (41.3) 0.052
Painful palpation to masticatory muscles 143 62 (43.4) 74 25 (33.8) 0.173
Painful palpation at the TMJ lateral pole 145 49 (33.8) 75 15 (20.0) 0.033
Painful palpation at the TMJ around lateral pole 145 56 (38.6) 75 19 (25.3) 0.049
sDMARDs Synthetic disease-modifying antirheumatic-drugs; methotrexate, mykofenolatmofetil, bDMARDs Biologic disease-modifying antirheumatic- drugs;
etanercept, infliximab, adalimumab, tocilizumab, abatacept, certolizumab, golimumab, TMJ temporomandibular joint, * Chi-square test
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the American Academy of Orofacial Pain [32] form for
screening and the RDC/TMD [31] for clinical examin-
ation in a population of 934 individuals aged 10–14
years. Thus it is clear that it can be challenging to get an
exact figure on the prevalence of TMD in the normal
population. A previous meta-analysis conducted by da
Silva and colleagues showed the overall prevalence of
intra-articular joint disorder to be 16% [33].
In our study, approximately half of the JIA subjects had
clinical findings consistent with TMD, with no differences
according to JIA category. Because the numbers for three
of the categories – systemic arthritis, rheumatoid factor
positive polyarthritis, and psoriatic arthritis – were rela-
tively low, these results should be interpreted with caution.
The sensitivity and specificity of the clinical orofacial
examination in relation to TMJ has been debated be-
cause displacement of the disc, although eliciting a click-
ing sound, might be asymptomatic [34–36]. Based on
the DC/TMD criteria, asymptomatic TMJ clicking is still
defined as TMD. However, several studies have shown
that pain-free clicking represents a normal variant, typic-
ally seen in girls during puberty [15]. Recently, a clinical
examination protocol for JIA was developed by the Tem-
poromandibular Joint Juvenile Arthritis Working Group
(TMJaw). This examination protocol focuses on three
general items, namely TMJ symptoms, TMJ dysfunction,
and dentofacial deformity in JIA, and it shows acceptable
reliability and validity [7].
We found, in accordance with other studies, that the
TMJ area and the masseter muscle region were common
locations for pain in JIA [29]. However, a recent study
from Koos and colleagues reported a lower frequency of
masticatory pain on palpation [15], and Kristensen and
colleagues stated that masticatory pain complaints could
develop over time [37]. In the present study, more than
half of the participants with JIA showed clinical signs in
the TMJ region and the masseter region, and more than
one-fourth of the participants with JIA had TMD. A lon-
gitudinal multicentre approach might elucidate the de-
velopment of masticatory muscle pain, as Kristensen and
colleagues have suggested [37].
The vertical unassisted jaw movement has been widely
used as a valid marker for TMJ arthritis [38]. We
showed that participants with JIA had lower vertical un-
assisted movements compared to their healthy peers, but
the differences were relatively small, thus questioning its
clinical significance. Viewed differently, for children and
adolescents aged < 11 years, the cut-off value of 40 mm
was within the range of normal vertical jaw movement
[39]. Further, our findings suggest that lateral movement
did not differ significantly between the two groups,
which is in line with the results of Twilt and colleagues
[40] and Küseler and colleagues [19]. In the latter study
of 15 children with JIA with a mean age of 12 years, the
recorded decreased lateral movements were ≤ 5 mm with
no significant relevance [19].
We found no statistically significant differences in the
presence of TMD according to JIA categories. However,
we found a significantly higher occurrence of clinical
signs in participants with JIA currently on DMARDs
medication (whether synthetic or biologic) compared to
those not taking such medication. A high risk of devel-
oping clinical signs of TMD was associated with a severe
disease course, as indicated by the use of DMARDs.
The strengths of this study are the relatively large
number of participants, in which the study groups were
well matched, and the meticulous standardisation of the
clinical TMJ assessment performed prior to and during
the study period. However, the large number of partici-
pants should not hide the fact that we are dealing with
an underpowered sample size that was lacking 75 partic-
ipants. An additional limitation is that the overall re-
sponse rate of 63%, although considered acceptable,
might have influenced the results because the group that
did not participate was, on average, slightly younger and
had a somewhat lower proportion of girls. Also, the
shortened version of the DC/TMD used in this study is
not directly comparable with studies having used the full
DC/TMD score. In the present study, children and ado-
lescents with JIA with TMD involvement were defined
based on clinical examination, and both self-reported
and parent-reported pain. Further studies will focus on
the role of imaging on the diagnosis of TMJ arthritis in
children and adolescents with JIA. Clinical orofacial
examination may not be reliable for diagnosing disc dis-
placement without reduction [5]. Imaging diagnosis is
particularly important in JIA with non-symptomatic
TMJ involvement because hard tissue loss in the condyle
might hinder the growth of the mandible and subse-
quently affect chewing function and cause aesthetic
problems [15].
Conclusion
Symptoms or clinical signs of TMD were seen in ap-
proximately half of the participants with JIA compared
to about one fourth of their healthy peers. Painful palpa-
tion of masticatory muscles and decreased vertical un-
assisted jaw movement are more frequent in children
with JIA than in healthy controls and should be part of
both medical and dental routine examinations in the
follow-up of JIA.
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